Charlotte Berg leaves the position as CEO of IDL Biotech AB (publ) | IDL Biotech
IDL Biotech

CLOSE MENU

Articles

Latest News

August 2020

Charlotte Berg leaves the position as CEO of IDL Biotech AB (publ)

IDL Biotech's CEO, Charlotte Berg, has informed the Board that, after more than ten years at the company, she wishes to resign as CEO to start another assignment in a non-competing company.

Read the press release here 

AroCell AB (publ) riktar offentligt uppköpserbjudande till aktieägarna i IDL Biotech AB (publ)

IDL Biotech AB uppmärksammar härmed att AroCell AB (publ) idag har lämnat ett uppköpserbjudande till aktieägarna i IDL att överlåta samtliga aktier till AroCell i utbyte mot 0,63 AroCell-aktier för varje aktie i IDL.

IDL Biotech is making progress in Africa

IDL Biotech has now received its first order from the company's distributor in Uganda, Medilink Lab & Surgical Ltd. The order refers to TUBEX® TF, IDL Biotech's rapid test for typhoid fever. Uganda will thus be the third country in Africa to which the company delivers TUBEX® TF.

IDL Biotech

Skip this intro